For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and the formulated version represents a true advancement . These innovative therapies protect the transthyretin protein, slowing its harmful build-up and alleviating the impact of the disease . Patients are now experienc… Read More